drugset / Trial / NCT03758339
A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
This study will look at how a drug (tucatinib) leaves the body and what happens to tucatinib while it is still in the body. Healthy participants will get one dose of tucatinib by mouth. Patients will be monitored for 8-14 days after they take the dose of tucatinib.
Timeline
- Start
- 2017-12-30
- Primary completion
- 2018-01-30
- Completion
- 2018-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tucatinib | Small molecule | 300 mg | Oral |
Indications
No indication recorded.